Profile
| Metric | Value |
|---|---|
| Full Name | Surgery Partners, Inc. |
| Ticker | NASDAQ: SGRY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | surgerypartners.com |
| Employees | 15,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $15.91 | |
| Price, 1D Change | +1.73% | |
| Market Cap | $2B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.71 | |
| Revenue | $3B | |
| Revenue, 1Y Change | +13.52% | |
| EPS | -$1.33 | |
| EPS, 1Y Change | -1,307.39% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.33 | |
| EPS Estimate | $0.64 | |
| EPS Est. Change | +147.76% | |
| Revenue | $3.11B | |
| Revenue Estimate | $3.29B | |
| Revenue Est. Change | +5.65% | |
| Current Price | $15.91 | |
| Price Target | - | $28.00 |
| Price Tgt. Change | - | +75.99% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.93 | -$0.09 | -110.18% | |
| $0.85 | -$1.33 | -256.82% | |
| $0.64 | N/A | +147.76% | |
| $0.69 | N/A | +151.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.75B | $2.74B | -0.24% | |
| $3.08B | $3.11B | +1.18% | |
| $3.29B | N/A | +5.65% | |
| $3.56B | N/A | +14.38% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -25.06% | |
| Price, 3Y | -42.85% | |
| Market Cap, 1Y | -23.74% | |
| Market Cap, 3Y | -41.32% | |
| Revenue, 1Y | +13.52% | |
| Revenue, 3Y | +39.96% | |
| EPS, 1Y | -1,307.39% | |
| EPS, 3Y | -18.88% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $15.91 | |
| SMA 200 | $20.94 | |
| SMA 200 vs Price | +31.62% | |
| SMA 50 | $17.23 | |
| SMA 50 vs Price | +8.31% | |
| Beta | 0.71 | |
| ATR | $0.53 | |
| 14-Day RSI | 42.01 | |
| 10-Day Volatility | 17.75% | |
| 1-Year Volatility | 48.21% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $3.11B | |
| EPS | -$1.33 | |
| Gross Profit | $593.00M | |
| Gross Margin | 19.04% | |
| Operating Profit | $454.30M | |
| Operating Margin | 14.59% | |
| Net Income | $12.50M | |
| Net Margin | 0.40% | |
| EBITDA | $607.80M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 2.07 | |
| Current Ratio | 1.79 | |
| Quick Ratio | 1.65 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 0.80 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 0.63 | |
| PB Ratio | 1.19 | |
| EV/EBITDA | 8.73 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.79B | |
| Cash & Equivalents | $269.50M | |
| Total Assets | $8.01B | |
| Current Assets | $1.12B | |
| Total Liabilities | $4.37B | |
| Current Liabilities | $624.40M | |
| Total Debt | $3.70B | |
| Short Term Debt | $142.40M | |
| Accounts Payable | $208.70M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $3.28B | |
| Operating Expenses | $138.70M | |
| Cost Of Goods Sold | $2.52B | |
| SG&A | $0.00 | |
| D&A | $152.60M | |
| Interest Expense | $0.00 | |
| Income Tax | $134.60M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $300.10M | |
| CFI | -$488.50M | |
| CFF | $262.00M | |
| Capex | $90.40M | |
| Free Cash Flow | $209.70M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Mizuho | → | |
| JP Morgan | → | |
| Barclays | → | |
| Mizuho | → | |
| UBS | → | |
| RBC Capital | → | |
| Benchmark | → | |
| Cantor Fitzgerald | → | |
| Barclays | → | |
| Benchmark | → |
Analyst sentiment
Institutional ownership
Screeners with SGRY
Data Sources & References
- SGRY Official Website www.surgerypartners.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1638833/000163883325000163/0001638833-25-000163-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1638833/000163883325000053/0001638833-25-000053-index.htm
- SGRY Profile on Yahoo Finance finance.yahoo.com/quote/SGRY
- SGRY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sgry
FAQ
What is the ticker symbol for Surgery Partners, Inc.?
The ticker symbol for Surgery Partners, Inc. is NASDAQ:SGRY
Does Surgery Partners, Inc. pay dividends?
No, Surgery Partners, Inc. does not pay dividends
What sector is Surgery Partners, Inc. in?
Surgery Partners, Inc. is in the Healthcare sector
What industry is Surgery Partners, Inc. in?
Surgery Partners, Inc. is in the Medical Care Facilities industry
What country is Surgery Partners, Inc. based in?
Surgery Partners, Inc. is headquartered in United States
When did Surgery Partners, Inc. go public?
Surgery Partners, Inc. initial public offering (IPO) was on September 30, 2015
Is Surgery Partners, Inc. in the S&P 500?
No, Surgery Partners, Inc. is not included in the S&P 500 index
Is Surgery Partners, Inc. in the NASDAQ 100?
No, Surgery Partners, Inc. is not included in the NASDAQ 100 index
Is Surgery Partners, Inc. in the Dow Jones?
No, Surgery Partners, Inc. is not included in the Dow Jones index
When was Surgery Partners, Inc. last earnings report?
Surgery Partners, Inc.'s most recent earnings report was on November 10, 2025
When does Surgery Partners, Inc. report earnings?
The next expected earnings date for Surgery Partners, Inc. is March 2, 2026